The Effects of Light-Targeted Balance Training on Balance, Functional Performance, and Fear of Falling in Individuals With a History of Falls
27 de agosto de 2026 actualizado por: Uskudar University
The Effects of Light-Targeted Balance Training on Balance, Functional Performance, and Fear of Falling in Individuals With a History of Falls: A Randomized Controlled Trial
In recent years, exercise programs based on visual stimuli have been reported to improve balance and motor control . However, studies investigating the effects of light-targeted balance training on balance, functional performance, and fear of falling in individuals with a history of falls are limited.
The aim of this study is to determine the effects of light-targeted balance training on balance, functional performance, and fear of falling in individuals with a history of falls. In addition, the study aims to investigate whether this training method provides additional benefits compared with traditional balance training. The findings of this study are expected to contribute to the development of rehabilitation programs aimed at preventing falls.
Descripción general del estudio
Estado
Reclutamiento
Condiciones
Intervención / Tratamiento
Descripción detallada
Inclusion Criteria
- Having experienced at least one fall within the previous 12 months.
- Being 18 years of age or older.
- Being able to walk independently or with the assistance of a walking aid.
- Being able to understand and follow verbal and visual instructions.
- Providing voluntary consent to participate in the study and signing the informed consent form.
Exclusion Criteria
- Presence of an acute orthopedic injury or an active musculoskeletal condition causing pain.
- Having undergone lower extremity surgery within the previous 6 months.
- Having advanced neurological disorders (e.g., advanced Parkinson's disease, advanced dementia).
- Having severe vestibular dysfunction or significant visual impairment.
- Having a cardiovascular condition that contraindicates exercise.
- Having advanced systemic diseases that significantly impair balance.
Tipo de estudio
Intervencionista
Inscripción (Estimado)
50
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Estudio Contacto
- Nombre: Shirin Khezritomatari
- Número de teléfono: +905342494709
- Correo electrónico: shirin.khezry8401@gmail.com
Ubicaciones de estudio
-
-
Istanbul
-
Istanbul, Istanbul, Turquía (Türkiye), 34000
- Reclutamiento
- Uskudar University
-
Contacto:
- Shirin Khezritomatari, Master student
- Número de teléfono: +905342494709
- Correo electrónico: Shirin.khezry8401@gmail.com
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
No
Descripción
Inclusion Criteria:
- History of at least one fall within the past 12 months
- Age 18 years or older
- Ability to walk independently or with an assistive device
- Ability to understand and follow verbal and visual instructions
- Voluntary participation in the study and provision of written informed consent by signing the informed consent form
Exclusion Criteria:
- Acute orthopedic injury or an active musculoskeletal condition causing pain
- History of lower extremity surgery within the past 6 months
- Advanced neurological disorders (e.g., advanced Parkinson's disease, advanced dementia)
- Severe vestibular dysfunction or significant visual impairment
- Medical conditions that contraindicate exercise due to severe cardiovascular disease
- Advanced systemic diseases that severely affect balance
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Experimental Group
Participants in this group will receive light-targeted balance training in addition to the standard program.
|
Exercises aimed at improving coordination, balance, and functional performance using visual and auditory cues.
|
|
Comparador activo: Control Group
Participants in this group will receive standard balance exercises.
|
Conventional balance training exercises.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Balance Performance (Berg Balance Scale)
Periodo de tiempo: Baseline and after 8 weeks of intervention
|
Balance performance is assessed using the Berg Balance Scale (BBS).
The scale consists of 14 functional tasks scored from 0 to 4. The total score ranges from 0 to 56, where higher scores indicate better balance and lower fall risk.
|
Baseline and after 8 weeks of intervention
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Functional Mobility (Timed Up and Go Test - TUG)
Periodo de tiempo: Baseline and after 8 weeks of intervention
|
Dynamic balance and mobility are assessed using the Timed Up and Go (TUG) test.
The time (in seconds) taken to stand up from a chair, walk 3 meters, turn around, walk back, and sit down is recorded.
Shorter completion times indicate better mobility.
|
Baseline and after 8 weeks of intervention
|
|
Change in Dynamic Balance (Y-Balance Test)
Periodo de tiempo: Baseline and after 8 weeks of intervention
|
Dynamic postural control is evaluated using the Y-Balance Test (YBT) in anterior, posteromedial, and posterolateral reach directions for both lower extremities.
Reach distance is normalized to limb length ((reach distance / limb length) x 100) and composite scores are calculated.
|
Baseline and after 8 weeks of intervention
|
|
Change in Lower Body Strength (30-Second Chair Stand Test)
Periodo de tiempo: Baseline and after 8 weeks of intervention
|
Lower extremity functional muscle strength is measured using the 30-Second Chair Stand Test.
The total number of full stands completed from a seated position in 30 seconds is recorded.
A higher number of repetitions indicates greater lower body strength.
|
Baseline and after 8 weeks of intervention
|
|
Change in Gait Speed (10-Meter Walk Test - 10MWT)
Periodo de tiempo: Baseline and after 8 weeks of intervention
|
Walking speed is assessed using the 10-Meter Walk Test (10MWT).
Participants walk a 10-meter course at their comfortable and/or fast walking pace, and the time taken (in seconds) to traverse the intermediate 6 meters is recorded to calculate gait speed (m/s).
|
Baseline and after 8 weeks of intervention
|
|
Change in Fear of Falling (Falls Efficacy Scale-International - FES-I)
Periodo de tiempo: Baseline and after 8 weeks of intervention
|
Fear of falling is evaluated using the 16-item Falls Efficacy Scale-International (FES-I).
Each item is scored on a 4-point Likert scale from 1 (not at all concerned) to 4 (very concerned).
Total score ranges from 16 to 64, with higher scores reflecting greater fear of falling.
|
Baseline and after 8 weeks of intervention
|
|
Change in Balance Confidence (Activities-specific Balance Confidence Scale - ABC)
Periodo de tiempo: Baseline and after 8 weeks of intervention
|
Balance confidence is measured using the 16-item Activities-specific Balance Confidence (ABC) Scale.
Participants rate their confidence in performing specific activities without losing balance on a scale from 0% to 100%.
The overall score is the mean percentage across all items.
|
Baseline and after 8 weeks of intervention
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
31 de julio de 2026
Finalización primaria (Estimado)
30 de septiembre de 2026
Finalización del estudio (Estimado)
30 de septiembre de 2026
Fechas de registro del estudio
Enviado por primera vez
15 de agosto de 2026
Primero enviado que cumplió con los criterios de control de calidad
15 de agosto de 2026
Publicado por primera vez (Actual)
20 de agosto de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
31 de agosto de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
27 de agosto de 2026
Última verificación
1 de agosto de 2026
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- 61351342/020-2288
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .